Literature DB >> 29937068

Beyond viral dependence: The pathological consequences of HCV-induced EGF signaling.

Armando Andres Roca Suarez1, Thomas F Baumert2, Joachim Lupberger1.   

Abstract

Entities:  

Keywords:  Chemokines; EGF; HCV; TC-PTP; Virus-host interaction

Mesh：

Substances：

Year:  2018        PMID： 29937068      PMCID： PMC7613413          DOI： 10.1016/j.jhep.2018.05.033

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   30.083


× No keyword cloud information.
  22 in total

Review 1.  Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study.

Authors: 
Journal:  Lancet Gastroenterol Hepatol       Date:  2016-12-16

2.  Epidermal growth factor receptor inhibition attenuates liver fibrosis and development of hepatocellular carcinoma.

Authors:  Bryan C Fuchs; Yujin Hoshida; Tsutomu Fujii; Lan Wei; Suguru Yamada; Gregory Y Lauwers; Christopher M McGinn; Danielle K DePeralta; Xintong Chen; Toshihiko Kuroda; Michael Lanuti; Anthony D Schmitt; Supriya Gupta; Andrew Crenshaw; Robert Onofrio; Bradley Taylor; Wendy Winckler; Nabeel Bardeesy; Peter Caravan; Todd R Golub; Kenneth K Tanabe
Journal:  Hepatology       Date:  2014-02-28       Impact factor: 17.425

Review 3.  Pathogenesis and prevention of hepatitis C virus-induced hepatocellular carcinoma.

Authors:  Yujin Hoshida; Bryan C Fuchs; Nabeel Bardeesy; Thomas F Baumert; Raymond T Chung
Journal:  J Hepatol       Date:  2014-11-03       Impact factor: 25.083

4.  Nonstructural 3/4A protease of hepatitis C virus activates epithelial growth factor-induced signal transduction by cleavage of the T-cell protein tyrosine phosphatase.

Authors:  Erwin Daniel Brenndörfer; Juliane Karthe; Lars Frelin; Patricia Cebula; Andreas Erhardt; Jan Schulte am Esch; Hartmut Hengel; Ralf Bartenschlager; Matti Sällberg; Dieter Häussinger; Johannes Georg Bode
Journal:  Hepatology       Date:  2009-06       Impact factor: 17.425

5.  Hepatitis C virus induces epidermal growth factor receptor activation via CD81 binding for viral internalization and entry.

Authors:  Jingyu Diao; Homer Pantua; Hai Ngu; Laszlo Komuves; Lauri Diehl; Gabriele Schaefer; Sharookh B Kapadia
Journal:  J Virol       Date:  2012-08-01       Impact factor: 5.103

6.  Epidermal growth factor receptor signaling impairs the antiviral activity of interferon-alpha.

Authors:  Joachim Lupberger; François H T Duong; Isabel Fofana; Laetitia Zona; Fei Xiao; Christine Thumann; Sarah C Durand; Patrick Pessaux; Mirjam B Zeisel; Markus H Heim; Thomas F Baumert
Journal:  Hepatology       Date:  2013-09-05       Impact factor: 17.425

7.  Clearance of persistent hepatitis C virus infection in humanized mice using a claudin-1-targeting monoclonal antibody.

Authors:  Fei Xiao; Joachim Lupberger; Laurent Mailly; Garrick K Wilson; Philippe Aubert; François H T Duong; Diego Calabrese; Céline Leboeuf; Isabel Fofana; Christine Thumann; Simonetta Bandiera; Marc Lütgehetmann; Tassilo Volz; Christopher Davis; Helen J Harris; Christopher J Mee; Erika Girardi; Béatrice Chane-Woon-Ming; Maria Ericsson; Nicola Fletcher; Ralf Bartenschlager; Patrick Pessaux; Koen Vercauteren; Philip Meuleman; Pascal Villa; Lars Kaderali; Sébastien Pfeffer; Markus H Heim; Michel Neunlist; Mirjam B Zeisel; Maura Dandri; Jane A McKeating; Eric Robinet; Thomas F Baumert
Journal:  Nat Biotechnol       Date:  2015-03-23       Impact factor: 54.908

8.  The role of EGF-EGFR signalling pathway in hepatocellular carcinoma inflammatory microenvironment.

Authors:  Peixin Huang; Xiaojing Xu; Lingyan Wang; Bijun Zhu; Xiangdong Wang; Jingling Xia
Journal:  J Cell Mol Med       Date:  2013-11-25       Impact factor: 5.310

9.  EGFR has a tumour-promoting role in liver macrophages during hepatocellular carcinoma formation.

Authors:  Hanane Lanaya; Anuradha Natarajan; Karin Komposch; Liang Li; Nicole Amberg; Lei Chen; Stefanie K Wculek; Martina Hammer; Rainer Zenz; Markus Peck-Radosavljevic; Wolfgang Sieghart; Michael Trauner; Hongyang Wang; Maria Sibilia
Journal:  Nat Cell Biol       Date:  2014-08-31       Impact factor: 28.824

10.  The hepatitis C virus non-structural protein NS5A alters the trafficking profile of the epidermal growth factor receptor.

Authors:  Jamel Mankouri; Stephen Griffin; Mark Harris
Journal:  Traffic       Date:  2008-06-09       Impact factor: 6.215
View more
  4 in total

1.  Strategies Targeting the Innate Immune Response for the Treatment of Hepatitis C Virus-Associated Liver Fibrosis.

Authors:  Daniel Sepulveda-Crespo; Salvador Resino; Isidoro Martinez
Journal:  Drugs       Date:  2021-01-05       Impact factor: 9.546

2.  Safety and Antiviral Activity of EGFR Inhibition by Erlotinib in Chronic Hepatitis C Patients: A Phase Ib Randomized Controlled Trial.

Authors:  Antonio Saviano; François Habersetzer; Joachim Lupberger; Pauline Simo-Noumbissie; Catherine Schuster; Michel Doffoël; Catherine Schmidt-Mutter; Thomas F Baumert
Journal:  Clin Transl Gastroenterol       Date:  2022-06-01       Impact factor: 4.396

Review 3.  Hepatitis C Virus and Hepatocellular Carcinoma: When the Host Loses Its Grip.

Authors:  Kaku Goto; Armando Andres Roca Suarez; Florian Wrensch; Thomas F Baumert; Joachim Lupberger
Journal:  Int J Mol Sci       Date:  2020-04-26       Impact factor: 5.923

Review 4.  Rewiring Host Signaling: Hepatitis C Virus in Liver Pathogenesis.

Authors:  Alessia Virzì; Armando Andres Roca Suarez; Thomas F Baumert; Joachim Lupberger
Journal:  Cold Spring Harb Perspect Med       Date:  2020-01-02       Impact factor: 5.159
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.